BG100921A - Средство и метод за лечение на автоимунни заболявания - Google Patents

Средство и метод за лечение на автоимунни заболявания

Info

Publication number
BG100921A
BG100921A BG100921A BG10092196A BG100921A BG 100921 A BG100921 A BG 100921A BG 100921 A BG100921 A BG 100921A BG 10092196 A BG10092196 A BG 10092196A BG 100921 A BG100921 A BG 100921A
Authority
BG
Bulgaria
Prior art keywords
glycoprotein
animal
treatment
agent
diseases
Prior art date
Application number
BG100921A
Other languages
English (en)
Other versions
BG62759B1 (bg
Inventor
�Eoh�� Ka�Apaba
Original Assignee
Иван Николаевич Головистиков
Лeohид Язohobич Kaчapaba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Иван Николаевич Головистиков, Лeohид Язohobич Kaчapaba filed Critical Иван Николаевич Головистиков
Publication of BG100921A publication Critical patent/BG100921A/bg
Publication of BG62759B1 publication Critical patent/BG62759B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Средството за лечение на автоимунни заболявания симунодефицит на супресорни клетки включва трофобластичен бета-1-гликопротеин (ТБГ).Методът се състои в прилагане на имунокоригиращ препарат, по-специално трофобластичен бета-1-гликопротеин (ТБГ), като начинът на приложение се определя чрез изследване на мононуклеарни клетки (МНК) за чувствителност спрямо него.
BG100921A 1994-03-18 1996-10-18 Средство и метод за лечение на автоимунни заболявания BG62759B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU9494008169A RU2056852C1 (ru) 1994-03-18 1994-03-18 Средство для лечения аутоиммунных заболеваний с иммунодефицитом супрессоров и способ лечения аутоиммунных заболеваний
PCT/RU1995/000047 WO1995025531A1 (en) 1994-03-18 1995-03-16 Means for treating auto-immune diseases and method of treatment

Publications (2)

Publication Number Publication Date
BG100921A true BG100921A (bg) 1997-12-30
BG62759B1 BG62759B1 (bg) 2000-07-31

Family

ID=20153349

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100921A BG62759B1 (bg) 1994-03-18 1996-10-18 Средство и метод за лечение на автоимунни заболявания

Country Status (22)

Country Link
US (1) US6150326A (bg)
EP (1) EP0790059B1 (bg)
JP (1) JPH09510473A (bg)
KR (1) KR100382252B1 (bg)
CN (1) CN1146156A (bg)
AT (1) ATE260111T1 (bg)
AU (1) AU699896B2 (bg)
BG (1) BG62759B1 (bg)
CA (1) CA2185892A1 (bg)
CZ (1) CZ285856B6 (bg)
DE (2) DE69532611D1 (bg)
ES (1) ES2107980T1 (bg)
FI (1) FI963671A7 (bg)
GE (1) GEP20012377B (bg)
GR (1) GR980300023T1 (bg)
HU (1) HUT75720A (bg)
NO (1) NO963911L (bg)
PL (1) PL179765B1 (bg)
RU (1) RU2056852C1 (bg)
SK (1) SK281948B6 (bg)
UA (1) UA26939C2 (bg)
WO (1) WO1995025531A1 (bg)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2120298C1 (ru) * 1995-11-28 1998-10-20 Товарищество с ограниченной ответственностью "Верта" Иммуностимулятор и препарат на его основе
FR2747041B1 (fr) * 1996-04-05 1998-05-22 Cird Galderma Utilisation de derives benzonaphtaleniques pour la fabrication de medicaments destines au traitement des neuropathies
GB0030729D0 (en) * 2000-12-16 2001-01-31 Univ Nottingham Substituted-4-Quinolones
US20050032725A1 (en) * 2002-10-09 2005-02-10 Toerrx, Inc. Molecules preferentially associated with effector T cells or regulatory T cells and methods of their use
RU2303995C1 (ru) * 2006-04-28 2007-08-10 Халлар Абдумуслимович Алиханов Средство, обладающее иммунорегуляторным свойством и его применение для лечения аутоиммунных заболеваний

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0000938B1 (en) * 1977-08-22 1984-10-17 National Research Development Corporation Macromolecular covalent conjugates, methods for preparing and pharmaceutical compositions containing them
JPS61186322A (ja) * 1985-02-13 1986-08-20 Nippon Univ 免疾調節剤
IT1188646B (it) * 1986-04-09 1988-01-20 Ellem Ind Farmaceutica Tripeptide ad attivita' immunostimolante
US4803072A (en) * 1986-09-10 1989-02-07 Smithkline Beckman Corporation Immunomodulation
FR2609632B1 (fr) * 1987-01-21 1991-03-29 Shelly Marc Nouvelle application therapeutique de la 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinon-6-one et les compositions pharmaceutiques destinees a cet usage
US5169835A (en) * 1989-01-18 1992-12-08 Oklahoma Medical Research Foundation Pregancy specific proteins applications
FR2650183A1 (fr) * 1989-07-25 1991-02-01 Pasteur Institut Proteines immunostimulantes, anticorps monoclonaux et polyclonaux correspondants, hybridomes correspondants et application de ces produits a des fins therapeutiques et de diagnostic
US5118669A (en) * 1989-09-20 1992-06-02 Hitachi Chemical Co., Ltd. Peptides and intermediates therefor useful as antiallergic agents, vasodilators and immunoregulators
US5559097A (en) * 1990-01-12 1996-09-24 Idaho Research Foundation, Inc. Use of a pregnancy specific protein as an immunosuppressive
RU1836957C (ru) * 1990-03-25 1993-08-30 2-й Московский государственный медицинский институт им.Н.И.Пирогова Способ получени трофобластического бета @ -гликопротеина
GB2251186A (en) * 1990-12-04 1992-07-01 Randall Neal Gatz Polypeptide for use in treatment of autoimmune disease

Also Published As

Publication number Publication date
HUT75720A (en) 1997-05-28
KR970701557A (ko) 1997-04-12
EP0790059A4 (en) 2000-11-02
BG62759B1 (bg) 2000-07-31
GR980300023T1 (en) 1998-04-30
NO963911D0 (no) 1996-09-18
NO963911L (no) 1996-11-08
DE790059T1 (de) 1998-03-12
WO1995025531A1 (en) 1995-09-28
ATE260111T1 (de) 2004-03-15
AU699896B2 (en) 1998-12-17
PL316311A1 (en) 1997-01-06
SK118796A3 (en) 1997-06-04
US6150326A (en) 2000-11-21
FI963671L (fi) 1996-11-14
UA26939C2 (uk) 1999-12-29
FI963671A7 (fi) 1996-11-14
EP0790059A1 (en) 1997-08-20
CZ274796A3 (en) 1997-06-11
FI963671A0 (fi) 1996-09-17
RU2056852C1 (ru) 1996-03-27
ES2107980T1 (es) 1997-12-16
KR100382252B1 (ko) 2003-07-07
PL179765B1 (pl) 2000-10-31
CA2185892A1 (en) 1995-09-28
HU9602558D0 (en) 1996-11-28
EP0790059B1 (en) 2004-02-25
SK281948B6 (sk) 2001-09-11
DE69532611D1 (de) 2004-04-01
GEP20012377B (en) 2001-03-25
JPH09510473A (ja) 1997-10-21
AU2087495A (en) 1995-10-09
CN1146156A (zh) 1997-03-26
CZ285856B6 (cs) 1999-11-17

Similar Documents

Publication Publication Date Title
Farris et al. Development of hypertension in emotional gray Norway rats after air blasting
DE19975031I2 (de) Verwendung von 4-Aminosalicyls{ure als entz}ndungshemmender Wirkstoff.
EA199900494A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA199800563A1 (ru) Антагонисты гормона, высвобождающего гонадотропин
BG29132A3 (bg) Метод за получаване на циклохексанови производни
EA200001224A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
EA199900486A1 (ru) Применение сфингомиелиназы для повышения уровней церамидов в коже и слизистых оболочках, а также содержащие ее дерматологические и косметические композиции, которые удобны для местного применения
DE69430315D1 (de) Methoden zur (ex vivo) therapie mittels peptid - bestueckten antigen - praesentierenden zellen zur aktivierung von ctl
EA200001223A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200100103A1 (ru) Ингибиторы адгезии клеток
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
ATE34077T1 (de) Hautbehandlungsmittel.
EA199700241A1 (ru) Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран
DE69125855D1 (de) Therapeutisch wirksame, örtliche anwendung von st1435
ES8501630A1 (es) Un metodo para detectar o vigilar el estado de una condicion patologica humana que implica proteina de tejido conjuntivo.
DE69533311D1 (de) Verfahren zur behandlung von autoimmunerkrankungen mittels typ-1-interferonen
NO963911D0 (no) Innretning for behandling av autoimmune sykdommer og fremgangsmåte for behandling
SE7707889L (sv) Haptoglobinpreparat
SU605608A1 (ru) Способ исследовани ветвей магистральных кровеносных сосудов
GB2003887A (en) Isolation of peptides from urine
SU651805A1 (ru) Способ лечени заболеваний роговицы
WO1996032133A3 (de) Konjugat zur behandlung von entzündungs-, infektions- und/oder hauterkrankungen
FR2376664A1 (fr) Derive l-prolinamide et son utilisation comme moyen therapeutique pour le traitement des maladies des yeux
SU1165393A1 (ru) Способ возбуждени родовой де тельности